Lion (Spiden)
Spiden provides and develops products that enable real-time and continuous monitoring of blood biomarkers.
Freienbach, Switzerlandwww.spiden.com ↗
Total raised
€39M
€38,846,915
Funding rounds
2
Investors
9
distinct backers
Active since
2021-04
latest 2024-12
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood59
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ €30M+ raised
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-06 | Series A | €24M | — | View deal → |
| 2021-04-29 | Other | €15M | B-to-V Partners,Business Angels,Daniel Gutenberg,Edward Ludwig,Geberit,Kirill Evstratov+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy